JOSE ANGEL
FONTENLA GIL
Profesor titular de universidade
Publicacións nas que colabora con JOSE ANGEL FONTENLA GIL (9)
2023
-
8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies
European Journal of Medicinal Chemistry, Vol. 248
2021
-
Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug
European Journal of Pharmacology, Vol. 906
2020
-
Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies
Bioorganic Chemistry, Vol. 101
-
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy
Bioorganic Chemistry, Vol. 104
2017
-
MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis,: in vitro study, and docking calculations
MedChemComm, Vol. 8, Núm. 9, pp. 1788-1796
2014
-
Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases
Future Medicinal Chemistry, Vol. 6, Núm. 4, pp. 371-383
2013
-
Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study
European Journal of Medicinal Chemistry, Vol. 63, pp. 151-161
1993
-
Pyridazine derivatives. XI: Antihypertensive activity of 3‐hydrazinocycloheptyl[1,2‐c]pyridazine and its hydrazone derivatives
Journal of Pharmaceutical Sciences, Vol. 82, Núm. 3, pp. 286-290
1992
-
Effect of urethane on hydralazine-induced tachycardia in rats
General Pharmacology, Vol. 23, Núm. 6, pp. 1143-1147